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Abstract
Objectives: Initiation of antiretroviral therapy (ART) during pregnancy is critical to promote maternal health and prevent
mother-to-child HIV transmission (PMTCT). The separation of services for antenatal care (ANC) and ART may hinder antenatal
ART initiation. We evaluated ART initiation during pregnancy under different service delivery models in Cape Town, South
Africa.
Methods: A retrospective cohort study was conducted using routinely collected clinic data. Three models for ART initiation
in pregnancy were evaluated ART ‘integrated’ into ANC, ART located ‘proximal’ to ANC, and ART located some distance
away from ANC (‘distal’). Kaplan-Meier methods and Poisson regression were used to examine the association between
service delivery model and antenatal ART initiation.
Results: Among 14 617 women seeking antenatal care in the three services, 30% were HIV-infected and 17% were eligible
for ART based on CD4 cell count ,200 cells/mL. A higher proportion of women started ART antenatally in the integrated
model compared to the proximal or distal models (55% vs 38% vs 45%, respectively, global p = 0.003). After adjusting for
age and gestation at first ANC visit, women who at the integrated service were significantly more likely to initiate ART
antenatally (rate ratio 1.33; 95% confidence interval: 1.09–1.64) compared to women attending the distal model; there was
no difference between the proximal and distal models in antenatal ART initiation however (p = 0.704).
Conclusions: Integration of ART initiation into ANC is associated with higher levels of ART initiation in pregnancy. This and
other forms of service integration may represent a valuable intervention to enhance PMTCT and maternal health.
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Introduction
Lifelong triple-drug antiretroviral therapy (ART) initiation in
eligible HIV-infected women during pregnancy is an important
intervention both for preventing mother-to-child transmission
(PMTCT) of HIV infection [1] and reducing HIV-associated
maternal morbidity and mortality [2]. Although ART initiation in
pregnancy is important in promoting maternal and child health in
the context of HIV/AIDS, there is growing evidence that only a
fraction of eligible pregnant women receive ART before delivery
[3,4]. In most settings across sub-Saharan Africa, the design of
health systems is a fundamental hurdle to ART in pregnancy [5].
HIV-infected eligible women are identified through PMTCT
programmes within antenatal care (ANC), but ART initiation and
follow-up typically takes place at separate HIV care and treatment
services. Adult HIV care and treatment services are not well-
oriented to the needs of HIV-infected pregnant women [6],
leading to calls to integrate antenatal and HIV care and treatment
services by providing ART within ANC services [7,8].
Few studies have examined the impact of integrating ART
delivery into ANC services, and the results of these are mixed.
Findings from a systematic review of integrating ART into
maternal and child health services suggest that integration results
in higher ART enrolment and coverage, however, these findings
were limited to four studies which fitted strict selection criteria and
did not account for the variation in models of integrated care [9].
One study in Zambia demonstrated that providing ART within
ANC increased the uptake of ART but did not have any effect on
the time to initiation or retention in care [10]. Results from a study
in Malawi also showed that even with a series of interventions to
integrate services over three years, attrition and delays in referring
pregnant women for ART were experienced [11]. Another South
African study found that weekly provision of ART providers in
ANC reduced the median time to ART initiation [12]. However,
other studies have found no difference in the proportion of women
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initiating ART between integrated versus separate antenatal and
ART services [13]. Together, this evidence demonstrates that
integration of ART into ANC services may be feasible but does
not necessarily improve maternal and child health outcomes.
Furthermore, there is a general lack of consensus in health systems
research regarding the defining criteria of integration [14], and
models on the latter frequently vary in terms of their success in
different contexts [9]. In turn, there is a clear need for operational
research to understand the impacts integrating ANC and ART
services [15].
Previously, we examined models of care for ART initiation
during pregnancy in Cape Town, South Africa. In a cohort of
women from 2005, we found no differences in ART initiation
before delivery when comparing integrated versus separated
services [3]. However, that study took place at a time when
public sector ART services were relatively new in this setting, and
it is possible that differences between integrated and separated
services would only emerge over time as various models of care
become more routine. To test this hypothesis, we investigated
antenatal ART initiation among eligible pregnant women
attending three different antenatal care services across Cape
Town during 2008.
Methods
We identified retrospectively a cohort of pregnant women who
presented during the 2008 calendar year at three public sector
primary care antenatal services. PMTCT services have been
available in this setting from 2001 [16] and in 2004, PMTCT
protocols were redrafted to include referral of pregnant women
who were identified as ART-eligible to ART sites [17]. National
guidelines at the time of this study recommended ART initiation
in women with CD4 counts #200 cells/mL [18]. Over the course
of 2008, the sites began to roll out ART to women with CD4
counts #250 cells/mL [19]. Women who were eligible for ART
but who did not start antepartum may have received AZT during
the antenatal period and later initiated ART postpartum.
Services
The three participating services each implemented a different
model for delivering ART to eligible pregnant women. The first
(Site 1) consisted of an ‘integrated’ model in which women were
able to initiate ART within the antenatal clinic on one specific day
of the week when obstetricians with an HIV specialisation were on
site; this model of care was set up and overseen by an international
NGO supporting services in the district. The second (Site 2) we
denoted a ‘proximal’ approach in which women were referred by
letter to a separate ART service located within 100 metres of the
maternity unit on the same premises. The third service model, the
‘distal’ approach (Site 3), delivered ART at a separate primary
health care facility approximately three kilometres from the
antenatal service, also using a referral letter. Each site delivered
the same clinical services according to standard provincial ART
protocols, which included same day CD4 cell count testing, which
were processed at an external laboratory, with results being
available at the antenatal service within a week. Although there
was no active tracking system for the referral letter, psychosocial
support was provided to eligible women by trained lay counsellors.
Procedures
The cohort of ART-eligible pregnant women seeking care at
each site during 2008 was assembled from clinical and laboratory
records, linked by patients’ folder number, name and date of birth.
HIV counselling and testing, HIV status and CD4 cell counts and
obstetric data, came from routine service registers. In instances of
missing data, electronic medical records systems were accessed for
laboratory and obstetric information. To ascertain ART initiation
and coverage among eligible women, the electronic and paper
records of all 31 ART clinics (15 of which had electronic data at
the time) in Cape Town were examined.
Ethics Statement
Study approval was obtained from the University of Cape Town
Human Research Ethics Committee (approval reference: 054/
2007) and local government authorities, who approved the use of
routinely collected services data and waived the need for written
informed consent of those included in the cohort. The use of
personal identifiers for linkage purposes was approved and deemed
to be of minimal risk to patients attending the services. All data
were kept confidential and stripped of unique identifiers after data
collection was complete and the linkages had been made.
Measures
The primary outcome was ART initiation before delivery. ART
eligibility was based on a documented CD4 cell count during
pregnancy of #200 cells/mL. Antenatal ART initiation was
confirmed by an initiation date which fell between first antenatal
presentation and delivery date or in the event of no available
initiation date, affirmative evidence from the antenatal folder or
labour ward register indicating ART coverage. In cases of a
missing delivery date, antenatal ART initiation was considered
affirmative if the ART initiation date was within 90 days of
antenatal presentation, and postnatal initiation .90 days after
antenatal presentation. This was based on a calculation of the
average time between presentation and delivery in the cohort of
HIV-infected women. ART coverage was defined as the
proportion of all women on ART by the time of delivery,
including women who initiated ART during pregnancy plus
women already on ART at the time of presentation to antenatal
care.
Analysis
Data were analysed using Stata version 12 (STATA Corpora-
tion, College Station, USA). Proportions of women completing
each step of the PMTCT cascade were estimated according to
service delivery model. Bivariable associations were tested using
Pearson’s Chi-squared test and Kruskal-Wallis test. Kaplan-Meier
methods were used to calculate the proportion of eligible women
initiating ART before delivery. Poisson regression with robust
standard errors was used to examine whether the association
between ART initiation and service delivery model (integrated/
Site 1 vs proximal/Site 2 vs distal/Site 3) persisted after
adjustment for potential confounding variables. An iterative
modelling process was used to select and identify confounding
variables in the model building process. Model results are
expressed as rate ratios (RR) for antenatal ART initiation with
95% confidence intervals (CI).
Results
A total of 14,617 women presented for antenatal care across the
three antenatal services during 2008: 4879 at Site 1; 4990 at Site 2
and 4 748 at Site 3. Nine women were excluded from the analysis
due to early pregnancy loss or false-positive pregnancy testing
(Figure 1).
There were several significant differences in the characteristics
of women seeking care at the three sites (Table 1). The median age
at presentation was 25 years (Interquartile Range [IQR]: 22–30
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years), with slightly older women attending Site 1. HIV counselling
and testing uptake was high but varied between services, with Site
1 achieving higher uptake (99%) and Site 3 testing the lowest
proportion of women (89%; p,0.001). At Site 1, 32% of women
tested HIV-positive compared to 18% at Site 3 (p,0.001).
Overall, 3% of women did not have a CD4 cell count result
recorded either in paper or electronic sources, and this proportion
did not vary across sites. The median CD4 cell count among all
HIV-infected women was 373 cells/mL (IQR: 240–542), and 17%
of all women had CD4#200 cells/mL; this proportion varied
between sites with the largest proportion of eligible women at Site
2 (p = 0.037, Table 2). Across all sites, a further 27% of HIV-
infected women had a CD4 cell count of 200–350 cells/mL
(Table 2).
ART Initiation in Eligible Women
Of the 658 women with a CD4 cell count #200 cells/mL at the
three sites, 11% (n= 81) were already on ART at their first
antenatal visit. This proportion was significantly higher at Site 1
(14%) compared to the other sites (p = 0.04). When excluding
women on ART at presentation, the overall percentage of eligible
women who were initiated on ART during pregnancy was 46%.
There was a significant difference in the proportions of women
who initiated ART between the sites, with 55%, 38% and 45% of
eligible women initiating ART during pregnancy at sites 1
(integrated), 2 (proximal), and 3 (distal), respectively (global
p = 0.003). The remaining 333 women (54%) had no documen-
tation of antenatal ART initiation (comprising 42% of women who
did not initiate in pregnancy according to the record review, and
13% of women for whom records were missing) Among the
women initiating ART during pregnancy, 5% of women
presenting at Site 1 initiated at an ART service other than the
designated referral site, compared to 14% of women from Site 2
and 22% of women from Site 3 (Table 2).
Gestational Age at First Presentation
The estimated median gestational age at first antenatal
presentation among all ART-eligible women was 26 weeks
(IQR: 21–31 weeks) and varied significantly between the sites,
with women from Site 3 presenting at 23 weeks and women from
Sites 1 and 2 presenting at 26 and 27 weeks, respectively
(p,0.001). Across all sites, women who initiated ART presented at
a significantly earlier gestational age (23 weeks) compared to
women who did not start ART during pregnancy (29 weeks;
p,0.001). However, the median gestational age at the time of
antenatal ART initiation (31 weeks; IQR, 28–34 weeks) did not
vary by site (p = 0.946,Table 2).
In women who presented at or after 32 weeks’ gestation, there
was little difference in the proportion of women initiating ART
between sites (5%–6% across sites; p = 0.435). Instead, the overall
Figure 1. PMTCT Cascade depicting pregnant women accessing the three antenatal service models: HIV testing and ART eligibility.
doi:10.1371/journal.pone.0063328.g001
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differences between sites were observed in women who presented
before 32 weeks. At Site 1, 36% of all eligible women who
presented before 32 weeks’ gestation were initiated, while Site 2
initiated 27% and Site 3 initiated 20% of these women,
respectively.
Delays to Treatment Initiation
Figure 2 shows the proportions of eligible pregnant women
initiating ART over time prior to delivery. Overall, half of women
started ART within 49 days of their first antenatal care visit (IQR:
31–67 days). The median time to treatment initiation was
significantly lower at Site 1 (36 days) compared to Sites 2 and 3
(54 and 59 days, respectively) (p,0.001). There was no significant
difference in the median time to treatment initiation by CD4 cell
count (log-rank p= 0.503 comparing CD4 cell count #100 cells/
mL versus 101–200 cells/mL). In addition, a further 20% (125/617)
of eligible women who did not receive ART in pregnancy went on
to initiate up to 3 years postpartum. The median time of ART
initiation in this group was 34 weeks after delivery; the time to
postpartum initiation was not significantly associated with the
antenatal site (p = 0.149).
Characteristics of Women who did and did not Initiate
ART Antenatally
In a regression model predicting antenatal ART initiation
(Table 3), women who attended Site 1 (integrated model) were
significantly more likely to initiate ART in pregnancy (RR: 1.33;
95% CI: 1.09–1.64) compared to women attending Site 3 (distal
model) after adjusting for covariation in gestational age at booking
and maternal age. There was no difference in the probability of
antenatal ART initiation comparing Sites 2 and 3, however
(p = 0.704). In addition, increasing gestational age at first antenatal
presentation was associated with decreased probability of antena-
tal ART initiation. Compared to women presenting at or before
20 weeks’ gestational age, women presenting at 25–28, 29–32, 33–
36 and after 36 weeks’ gestational age were 28%, 38%, 78% and
82% less likely to start ART during the antenatal period.
Increasing maternal age was also associated with increasing
probability of antenatal ART initiation (RR for a 1-year increase
in age, 1.02; 95% CI: 1.00–1.03).
Discussion
This study examined antenatal ART initiation in eligible
pregnant women in Cape Town during 2008. Although overall
levels of ART initiation were relatively low, the findings suggest
that an integrated model of antenatal ART initiation may be
associated with higher ART uptake compared to models that
separate ANC and ART services.
The proportion of women starting ART in pregnancy in these
data from 2008 (46%) is slightly lower than the corresponding
proportion from the same facilities in 2005 (51%). These
persistently low levels of antenatal ART initiation point to the
ongoing challenges in starting ART during pregnancy. Health
services for ART initiation in adults expanded in Cape Town
between 2005 and 2008 (doubling from 33 clinics in 2005 to 66 in
2009). However, these general ART services are often not oriented
to the needs of pregnant women. First, pregnant women tend to be
clinically stable compared to other eligible adults [20,21] and may
not receive adequate attention in the general pool of more morbid
patients initiating treatment. Second, there are unique psychoso-
cial barriers facing pregnant women starting ART which receive
little attention in routine ART counselling models [22].
Here, the integrated model for starting ART in pregnancy saw a
higher percentage of women initiating ART before delivery. In
this model, the vast majority of women (95%) who started ART
antenatally did so within the ANC, compared to lower proportions
in the other models with referral ART services. Previous studies
have reported similarly low rates of ART initiation among women
referred to centralised ART services [4,23]. It may be possible that
with increased distance between antenatal and ART services,
factors such as convenience or desire for privacy may adversely
affect referral and uptake of ART. For example, qualitative
research from Malawi has suggested that pregnant women have a
preference for integrated ART services over access to ART in
general primary level services where they would be required to
mix with HIV-infected men and non-pregnant women with more
advanced HIV disease [24].
These findings also demonstrate that regardless of the model of
care involved, late antenatal presentation is a persistent barrier to
antenatal ART initiation. In this setting, women presented for care
in pregnancy into the second and third trimesters, decreasing the
time available for antenatal ART initiation. The phenomenon of
late antenatal presentation is a well-known concern in maternal
and child health [25–27], and our findings are consistent with
other studies [28,29]. The frequency of late antenatal presentation
in this and other settings means that expediting ART initiation in
Figure 2. Kaplan-Meier failure estimates of time to treatment in
women who initiated ART in pregnancy.
doi:10.1371/journal.pone.0063328.g002
Table 3. Poisson regression predicting the probability of
antenatal ART initiation among eligible pregnant women.
Variable Rate Ratio p-value
95% confidence
interval
Service delivery
model
Site 3 Reference
Site 2 1.05 0.704 (0.83–1.31)
Site 1 1.34 0.005 (1.09–1.64)
Gestational age at presentation
#20 weeks Reference
21–24 weeks 0.94 0.543 (0.78–1.14)
25–28 weeks 0.72 0.002 (0.58–0.88)
29–32 weeks 0.62 ,0.001 (0.48–0.79)
33–36 weeks 0.22 ,0.001 (0.13–0.38)
36–40 weeks 0.18 0.002 (0.06–0.54)
Maternal age 1.02 0.04 (1.00–1.03)
doi:10.1371/journal.pone.0063328.t003
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eligible women is critical, as are complementary efforts to
encourage women to attend antenatal care earlier [30]. The
median time to treatment in women who initiated postpartum was
34 weeks, which may suggest identification and linkage to care
through baby immunization services. More research is required to
understand the reasons for delayed initiation in these women who
were not lost to the service. Under the integrated model of care,
women started ART more quickly (median delay from antenatal
presentation to ART initiation, 36 days) than in other models
(median delay, 54 and 59 days at Sites 2 and 3, respectively).
Several studies have suggested that each additional week of ART
provided before delivery results in a significant reduction in the
risk of vertical transmission [31] pointing to additional potential
benefits to an integrated model of care for PMTCT.
Our findings are particularly important given the interest in
universal ART initiation for all HIV-infected pregnant women,
regardless of CD4 cell count [32]. Implementation of the World
Health Organization’s ‘‘Option B+’’ strategy would dramatically
increase the numbers of women eligible to start lifelong ART in
pregnancy in South Africa and other high-prevalence settings, and
would also require new service delivery approaches that can assist
in starting ART as quickly as possible during pregnancy.
Integration of ANC and ART services presents one valuable
strategy to achieve these aims. However, it is important to note
that this research focuses on ART initiation, and there are
separate concerns regarding treatment adherence and retention in
care among women starting ART during pregnancy [33]. These
issues are likely to persist across models of care, and will require
specific attention in the design and operation of integrated or
separated ART-ANC services.
The interpretation of these data comes with several limitations.
There may be important differences between the three service
delivery models other than their approach to antenatal ART
initiation and thus it is difficult to infer that the increased antenatal
ART initiation at Site 1 is attributable solely to the integration of
services. For example, we did not assess whether the time for
treatment workup differed between the models. Each ART eligible
woman would have required both clinical and psychosocial
assessment prior to initiation and it is possible that approaches
varied between the models and within the sites depending on
service provider. This may have negatively impacted on women
who presented in late pregnancy in particular, due to there being
little time for work up. Despite this, guidelines did not preclude
women in advanced pregnancy (.36 weeks gestation) from
initiating ART. Related to this, it is important to note that
definitions of service integration related to HIV/AIDS and
reproductive health vary widely [34]. The integration studied
here may not be appropriate in all settings and alternative
approaches to integration may be more relevant in other health
systems contexts; further research into integrated models of ANC
and ART is warranted.
This research was conducted in an urban setting with a high
antenatal HIV prevalence and high-volume ANC and ART
services, and the findings should be generalized with caution. This
analysis was conducted under previous WHO guidelines (with a
CD4 threshold for ART initiation of 200 cells/uL) and the
numbers of women requiring ART have almost doubled since the
implementation of the 2010 WHO guidelines; it is unclear
whether such increases would alter the differences shown here
between integrated and separated services. In addition, these data
come from a retrospective review of clinical records, and hence the
accuracy and completeness data may be suboptimal, though there
were no differences in the levels of missing data between service
delivery models.
In summary, with the efficacy of drug regimens for PMTCT
well-established, PMTCT programme impact is dependent on the
implementation of appropriate and effective service delivery
models [35]. This study suggests that integration of ART into
routine antenatal care services can lead to significant improve-
ments in ART initiation during pregnancy, increasing both the
proportion of eligible women who start ART and the duration of
ART received before delivery. While further research is required,
integration of ART into antenatal care represents a valuable
approach for promoting maternal and child health in the context
of HIV/AIDS.
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